|
Acronym |
Title |
Coordinating institution |
Partners |
Improving and upscaling primary prevention of cancer through implementation researchTotal EU funding: €50 million |
|||
|
Towards large-scale adoption and tailored implementation of evidence-based primary cancer prevention programmes in Europe and beyond. |
INSTITUT CATALA D'ONCOLOGIA - ICO |
15 partners: ES (3), NL (2), AL, IT, UA, BE, NO, DE (3), AU, UK |
|
|
Cancer prevention among individuals with mental ill-health: Co-adapting and implementing patient navigation for primary cancer prevention. |
MEDIZINISCHE UNIVERSITAET WIEN |
14 partners: AT, BE, ES (8), EL (2), NL, PL |
|
|
Improving and upscaling primary prevention of cancer by addressing childhood obesity through implementation research - the PREVENT approach |
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON - NKUA |
20 partners: BE (4), DE, EL (6), ES (3), IE, IT, SE (4) |
|
|
Evidence-based Participatory Decision Making for Cancer Prevention through implementation research |
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS - CENTRE FOR RESEARCH AND TECHNOLOGY HELLAS CERTH |
27 partners: GR (7), ES (3), BE (4), AT (2), RO (3), LT (3), NL, IT (2), CY, LU |
|
|
Personalised CANcer Primary Prevention research through Citizen Participation and digitally enabled social innovation |
ASOCIATIA CENTRUL PENTRU INOVATIE IN MEDICINA - CENTRE FOR INNOVATION IN MEDICINE |
17 partners: RO (5), UA, BE (2), MK, BG (2), MD, PT, ME, IT, IE, FR |
|
| CPW | Cancer Prevention at Work (CPW): Occupational health surveillance in the implementation of prevention of infection-related cancer. | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA - UNIBO | 19 partners: CZ, DE, DK, ES (3), IT (6), RO (4), SK (3) |
Strengthening research capacities of comprehensive cancer infrastructuresTotal EU funding: €10 million
|
|||
|
Comprehensive Cancer Infrastructures 4 Europe |
ORGANISATION OF EUROPEAN CANCER INSTITUTES - OECI |
BE (3), AT, FI, RO, BG, DK, IE, ES (2), LT, EE, GR, NL (3), DE (3), MD, SI, UA, PT, SK, IT (4), CY, SE (2), HR, FR (2), LU (2), NO, CZ, HU, PL (2), LV, MT |
|
Pragmatic clinical trials to optimise treatments for patients with refractory cancersTotal EU funding: €72.1 million |
|||
|
A precision medicine trial leveraging blood-based tumour genomics to optimise treatment in operable stage III and high-risk stage II colon cancer patients - The Sagittarius Trial. |
FONDAZIONE AIRC PER LA RICERCA SUL CANCRO ETS |
9 partners: BE, DE, EE, ES (2), IT (4) |
|
|
Lomustine with or without reirradiation for first progression of glioblastoma: a pragmatic randomized phase III study |
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL - EORTC |
5 partners: AT, BE, HU, IT, UK |
|
|
A European multi-disciplinary clinical project meant to improve the management of patients with poor prognostic ovarian cancer after neoadjuvant chemotherapy: Restoring hope, salvaging lives.
|
HOSPICES CIVILS DE LYON |
11 partners: BE, ES (2) FR (8) |
|
|
PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials |
OSLO UNIVERSITETSSYKEHUS HF - OUS |
24 partners: NO, NL (2), SE (5), DK, FI, FR, PT, DE, PL, HR, EE, HU, ES, LT, UK (2), IE, CZ, RO |
|
|
Intermittent androgen deprivation therapy in the era of androgen receptor pathway inhibitors; a phase 3 pragmatic randomised trial. |
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL - EORTC |
6 partners: BE (2), ES, FR, HU, IE |
|
| PragmaTIL | Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors | FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (VHIO) | 12 partners: DK, ES (5), FR (3), IL, NL, SE |
| CARE1 | First line randomised study platform to optimise treatment in patients with metastatic renal cell carcinoma | INSTITUT GUSTAVE ROUSSY | 16 partners: FR (6), DE (1), ES (3), NL (2), IT (1), AT (1), CZ (1), UK (1) |
| IMPORTANT | for dose Optimisation of CDK 4/6-inhibitors in older bReasT cAncer patieNTs | OREBRO LANS LANDSTING - Region Örebro County | 20 partners: BE, CH, EL (3), ES (3), FI, IE (2), IT (2), NL, NO, SE (4), UK |
| IntReALL 2020 | International Study for Treatment of Childhood Relapsed ALL 2020 | CHARITE - UNIVERSITAETSMEDIZIN BERLIN | 26 partners: DE (4), FR (3), IT, NL, CZ, GR, NO, RO, FI, HU, BE, DK, PT, IL, SI, AT, ES (2), PL, SE, CH |
| LIVERATION | Unravelling the impact of Radiofrequency in liver surgery: the key to decrease local recurrence? | CONSORCIO MAR PARC DE SALUT DE BARCELONA - IMIM |
12 partners: ES (8), PT, BE, GR, FR |
| IMPACT- AML | Master Framework and Pragmatic Clinical Trial for Relapse or Refractory Acute Myeloid Leukemia | ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI DINO AMADORI - IRST SRL - IRST | 17 partners: IT (5), ES (3), CY, DE (5), CZ, BE, LT |
| STREXIT2 | A pragmatic clinical study of neoadjuvant chemotherapy followed by surgery versus surgery alone for patients with high risk retroperitoneal sarcoma. | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL - EORTC | 5 partners: BE, IT, NL, HU, DE |
Establishing of national cancer mission hubs and creation of network to support the Mission on CancerTotal EU funding: €6 million |
|||
|
Establishing of Cancer Mission Hubs: Networks and Synergies |
AICIB - AGENCIA DE INVESTIGACAO CLINICA E INOVACAO BIOMEDICA |
57 partners: PT (2), AT, BE (2), CY, CZ (3), EE (2), FI (2), DE, GR, HU, IE (2), IL, IT (3), LT (7), LU (2), MT (2), NL, NO (5), PL (2), RO, SK (2), SI, ES (2), SE (4), FR, TR, LV (3), HR. |
|
Background information
The EU Cancer Mission aims to optimise the diagnosis and treatment and support the quality of life of cancer patients. It also focuses on preventing this life-threatening disease from affecting millions in the EU.
On 22 May 2022, HaDEA launched 1 call for proposals with 5 topics with a total funding of €126 million under the Horizon Europe programme to contribute to the swift implementation of the EU Cancer Mission. 20 proposals were shortlisted, resulting in 20 new collaborative projects.